Moderna aims to roll out a combined Covid-flu-RSV booster vaccine in late 2023, the US pharmaceutical firm said Monday, hoping a joint jab would encourage people to get an annual shot. 
The single vaccine for Covid-19, influenza and respiratory syncytial virus — a common virus that causes the cold, but can be more serious for infants and elderly people — could appear on the market before 2024.
“Best-case scenario will be the fall of ’23,” Moderna chief executive Stephane Bancel told a virtual World Economic Forum roundtable session.
“I don’t think it would happen in every country, but we believe it’s possible to happen in some countries next year.
“Our goal is to be able to have a single annual booster so that we don’t have compliance issues where people don’t want to get two to three shots a winter, but to get one dose.”
Trials in progress
Bancel said the RSV programme was in Phase III trials — the final stage of human testing — while the flu programme should be entering Phase III in the second quarter of this year.
Moderna’s experimental flu shot, targeting four major strains, is based on the same mRNA method used in its Covid-19 jabs.
The technology provokes an immune response by delivering genetic molecules containing the code for key parts of a pathogen into human cells.
While Moderna’s Covid-19 vaccine was based on the original strain of the virus, it was working on finishing an Omicron-specific jab within weeks, ahead of trials, said Bancel.
“We’re hoping in the March timeframe we should be able to have data to share with regulators to figure out the next step forward.”
Hunt for ‘holy grail’
Beyond a vaccine specific to Omicron — which is rapidly becoming the world’s dominant strain — laboratories are also pursuing a vaccine that works against all current and future Covid-19 mutations.
“There are some private sector partners that are pursuing it,” said Richard Hatchett, chief executive of the Coalition for Epidemic Preparedness Innovations, which funds vaccine research and development.
“That would be the holy grail because we really don’t want to be in a position where we’re chasing the new variants that are going to come.
“We don’t want to be in a position where we’re having to vaccinate everybody in the world every three or six months, or even annually, ideally.”
Top US pandemic advisor Anthony Fauci added: “We really don’t want to get into the whack-a-mole approach towards every new variant… because you’d be chasing it forever.”
Bancel meanwhile said that Moderna had shipped 807 million doses of the Covid-19 vaccine in 2021, of which a quarter went to middle- and low-income countries.
Thanks to extra capacity coming on stream before the end of March, the company hopes to be able to make two to three billion doses this year.
With Inputs from Agence France-Presse or AFP
healthNot Possible To End This Virus; Pandemic Viruses End Up Becoming Part Of Ecosystem: WHO Official
basicsPregnant, Lactating Mothers Made Aware Of Side Effects Of Covid-19 Vaccination, Centre Tell SC
healthFailure To Vaccinate Everyone Will Give Rise To New Variants: UN Chief
healthCOVID-19 Treatment: Govt Issues Revised Guidelines On Use Of Drugs, Therapies
healthAsymptomatic Animal Handlers Transmit COVID Delta Variant To Lions At Zoo In South Africa: Study
healthDr Angelique Coetzee: Don't Look At Your Positivity Rate, Look At How Many People Admitted In ICU
healthCOVID-19: Why T Cell Vaccines Could Be The Key To Long-Term Immunity
kidsChildren Exercised Less During COVID Lockdown – 4 Tips To get Them Moving Again
healthOmicron: Is Anti-Malaria Drug Hydroxychloroquine Really Effective Against The COVID Variant?
wellnessCOVID Vaccine 4th Dose Shows Limited Results With Omicron, Says Study In Israel
healthPhytochemicals Discovered In Himalayan Plant Buransh That Inhibit COVID-19 Virus
healthOmicron Viral Load At Its Highest On Day 5? A Scientific Understanding Of The Isolation Period
- Late Hugo Lloris penalty save ensures share of north London derby spoils after dramatic Wembley encounter
- Adam Reach believes Sheffield Wednesday can make a late challenge under Steve Bruce
- Adam Reach confident Sheffield Wednesday can make late playoff challenge under Steve Bruce
- Substitute Martin nets late hat-trick as Dons U18s mount comeback
- Gutsy Town bow out of cup on penalties
- Big win edges Lea ever closer to safety
- The Palace myth Blues can expose & why 'success' is hard for Silva
- Raheem Sterling scores twice as Manchester City canter to crucial three points at Crystal Palace
- BOWLS: Victory over closest rivals gives fighting chance of reaching finals
- Connah’s Quay 1-3 Ross County: Irn-Bru Cup stays in Scotland
- Toby Alderweireld own goal sends Liverpool fans into raptures as they beat Spurs at the last
- Arsenal draw with Brighton to all but end top four hopes
- Sokratis red leaves Arsenal huge task to overturn Rennes defeat and stay in Europa League
- Impressive Arsenal take two-goal lead to Italy after swashbuckling display against Napoli
- Liverpool storm into Champions League semi-final against Barcelona after battering Porto
- Eden Hazard scores two to beat West Ham
- Eden Hazard scores sensational solo goal with brace against West Ham
- Manchester United find Lionel Messi unstoppable once again as Barcelona cruise into Champions League semi-finals
- Liverpool stroll back to the top as Sadio Mane and Mohamed Salah double up to thrash Huddersfield
- SSE Women's FA Cup Final: West Ham 0 Manchester City 3
Covid-Flu Combined Booster Shot Possible Late 2023: Moderna have 914 words, post on www.boldsky.com at January 20, 2022. This is cached page on Health Breaking News. If you want remove this page, please contact us.